Callan Family Office LLC Raises Stock Position in Exelon Corporation $EXC

Callan Family Office LLC grew its holdings in shares of Exelon Corporation (NASDAQ:EXCFree Report) by 213.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,075 shares of the company’s stock after purchasing an additional 12,306 shares during the period. Callan Family Office LLC’s holdings in Exelon were worth $785,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Vanguard Group Inc. increased its stake in Exelon by 0.5% during the first quarter. Vanguard Group Inc. now owns 127,917,037 shares of the company’s stock worth $5,894,417,000 after purchasing an additional 581,686 shares during the period. Deutsche Bank AG increased its stake in shares of Exelon by 11.6% during the first quarter. Deutsche Bank AG now owns 19,077,520 shares of the company’s stock worth $879,092,000 after buying an additional 1,988,212 shares during the period. Massachusetts Financial Services Co. MA increased its stake in shares of Exelon by 0.7% during the first quarter. Massachusetts Financial Services Co. MA now owns 15,837,173 shares of the company’s stock worth $729,777,000 after buying an additional 106,917 shares during the period. Invesco Ltd. increased its stake in shares of Exelon by 0.6% during the first quarter. Invesco Ltd. now owns 13,802,263 shares of the company’s stock worth $636,008,000 after buying an additional 83,518 shares during the period. Finally, Northern Trust Corp increased its stake in shares of Exelon by 11.8% during the first quarter. Northern Trust Corp now owns 12,531,900 shares of the company’s stock worth $577,470,000 after buying an additional 1,319,637 shares during the period. 80.92% of the stock is currently owned by hedge funds and other institutional investors.

Exelon Stock Performance

Shares of Exelon stock opened at $46.85 on Tuesday. The firm has a market capitalization of $47.32 billion, a P/E ratio of 17.81, a P/E/G ratio of 2.91 and a beta of 0.40. Exelon Corporation has a 52 week low of $35.94 and a 52 week high of $48.11. The company has a quick ratio of 0.85, a current ratio of 0.95 and a debt-to-equity ratio of 1.66. The firm’s 50 day moving average is $44.44 and its two-hundred day moving average is $44.35.

Exelon (NASDAQ:EXCGet Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported $0.39 EPS for the quarter, beating the consensus estimate of $0.37 by $0.02. The company had revenue of $5.43 billion for the quarter, compared to analyst estimates of $5.47 billion. Exelon had a net margin of 11.16% and a return on equity of 9.85%. The firm’s revenue was up 1.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.47 earnings per share. Exelon has set its FY 2025 guidance at 2.640-2.740 EPS. Research analysts forecast that Exelon Corporation will post 2.64 EPS for the current fiscal year.

Exelon Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, September 15th. Investors of record on Monday, August 11th were issued a dividend of $0.40 per share. The ex-dividend date of this dividend was Monday, August 11th. This represents a $1.60 annualized dividend and a dividend yield of 3.4%. Exelon’s dividend payout ratio (DPR) is currently 60.84%.

Analyst Upgrades and Downgrades

EXC has been the topic of a number of recent research reports. UBS Group upped their target price on shares of Exelon from $48.00 to $50.00 and gave the stock a “neutral” rating in a research note on Friday. Evercore ISI initiated coverage on shares of Exelon in a research note on Monday, October 6th. They set an “outperform” rating and a $57.00 target price on the stock. Morgan Stanley cut their target price on shares of Exelon from $50.00 to $49.00 and set an “equal weight” rating on the stock in a research note on Thursday, September 25th. KeyCorp cut their target price on shares of Exelon from $39.00 to $37.00 and set an “underweight” rating on the stock in a research note on Wednesday, July 16th. Finally, Weiss Ratings reiterated a “buy (b-)” rating on shares of Exelon in a research note on Wednesday, October 8th. Five analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $48.33.

Check Out Our Latest Stock Analysis on Exelon

Exelon Profile

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Recommended Stories

Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Corporation (NASDAQ:EXCFree Report).

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.